4.1 Article

In Vitro and In Vivo Assessment of Renal Drug Transporters in the Disposition of Mesna and Dimesna

Related references

Note: Only part of the references are listed.
Article Pharmacology & Pharmacy

Drug Uptake Systems in Liver and Kidney: A Historic Perspective

B. Hagenbuch

CLINICAL PHARMACOLOGY & THERAPEUTICS (2010)

Review Biotechnology & Applied Microbiology

Membrane transporters in drug development

Kathleen M. Giacomini et al.

NATURE REVIEWS DRUG DISCOVERY (2010)

Article Physiology

Genetic variants of human organic anion transporter 4 demonstrate altered transport of endogenous substrates

James E. Shima et al.

AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2010)

Article Pharmacology & Pharmacy

Effects of Drug Transporters on Volume of Distribution

Anita Grover et al.

AAPS JOURNAL (2009)

Article Physiology

Organic anion transporter 3 (Oat3/Slc22a8) knockout mice exhibit altered clearance and distribution of penicillin G

Adam L. VanWert et al.

AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2007)

Article Pharmacology & Pharmacy

Intestinal drug transporter expression and the impact of grapefruit juice in humans

H. Glaeser et al.

CLINICAL PHARMACOLOGY & THERAPEUTICS (2007)

Article Pharmacology & Pharmacy

Irinotecan-induced diarrhea: Functional significance of the polymorphic ABCC2 transporter protein

F. A. de Jong et al.

CLINICAL PHARMACOLOGY & THERAPEUTICS (2007)

Article Pharmacology & Pharmacy

High-dose methotrexate in pediatric acute lymphoblastic leukemia:: Impact of ABCC2 polymorphisms on plasma concentrations

Thomas Rau et al.

CLINICAL PHARMACOLOGY & THERAPEUTICS (2006)

Article Chemistry, Medicinal

Thiol exchange:: An in vitro assay that predicts the efficacy of novel homocysteine lowering therapies

Bradley L. Urquhart et al.

JOURNAL OF PHARMACEUTICAL SCIENCES (2006)

Review Biochemistry & Molecular Biology

Drug-drug interactions involving membrane transporters in the human kidney

Meng Li et al.

EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2006)

Article Physiology

The human organic anion transporter 3 (OAT3; SLC22A8):: genetic variation and functional genomics

AR Erdman et al.

AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2006)

Article Biochemistry & Molecular Biology

Decreased renal organic anion secretion and plasma accumulation of endogenous organic anions in OAT1 knock-out mice

SA Eraly et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2006)

Article Multidisciplinary Sciences

A human transporter protein that mediates the final excretion step for toxic organic cations

M Otsuka et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)

Article Pharmacology & Pharmacy

Effect of probenecid on the pharmacokinetics of carbamazepine in healthy subjects

KA Kim et al.

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2005)

Article Pharmacology & Pharmacy

Different effects of three transporting inhibitors, verapamil, cimetidine, and probenecid, on fexofenadine pharmacokinetics

N Yasui-Furukori et al.

CLINICAL PHARMACOLOGY & THERAPEUTICS (2005)

Review Pharmacology & Pharmacy

Transporters and drug therapy: Implications for drug disposition and disease

RH Ho et al.

CLINICAL PHARMACOLOGY & THERAPEUTICS (2005)

Article Pharmacology & Pharmacy

Human organic anion transporter 4 is a renal apical organic anion/dicarboxylate exchanger in the proximal tubules

S Ekaratanawong et al.

JOURNAL OF PHARMACOLOGICAL SCIENCES (2004)

Article Pharmacology & Pharmacy

Pharmacoldnetics and preliminary clinical data of the novel chemoprotectant BNP7787 and cisplatin and their metabolites

M Verschraagen et al.

CLINICAL PHARMACOLOGY & THERAPEUTICS (2003)

Article Pharmacology & Pharmacy

Human organic anion transporting polypeptide-C (SLC21A6) is a major determinant of rifampin-mediated pregnane X receptor activation

RG Tirona et al.

JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2003)